Suchergebnisse - "Marquet, Alicia"

PubPharm (6)

1

Different phenotypes in dermatomyositis associated with anti-MDA5 antibody : Study of 121 cases

enthalten in: Neurology | 2020

von Allenbach, Y. | Uzunhan, Y. | Toquet, S. | +41

CommentIn: Front Immunol. 2024 Jan 08;14:1319957. - PMID 38259447

2

Outcome of patients with sarcoidosis refractory to TNF antagonists : a case series

enthalten in: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG | 2018

von Thery-Casari, C. | Jamilloux, Y. | Bouvry, D. | +10

3

Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis : A multicenter study of 132 patients

enthalten in: Seminars in arthritis and rheumatism | 2017

von Jamilloux, Y. | Cohen-Aubart, F. | Chapelon-Abric, C. | +23

4

Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis : A French Study of 46 Cases

enthalten in: JAMA dermatology | 2017

von Heidelberger, V. | Ingen-Housz-Oro, S. | Marquet, A. | +22

ErratumIn: JAMA Dermatol. 2017 Aug 1;153(8):837. - PMID 28746698

5

Efficacy and safety of TNF antagonists in ocular sarcoidosis : data from the French registry STAT

enthalten in: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG | 2017

von Marquet, A. | Chapelon-Abric, C. | Maucort-Boulch, D. | +20

6

Efficacy and safety of infliximab therapy in refractory upper respiratory tract sarcoidosis : experience from the STAT registry

enthalten in: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG | 2017

von Barba, T. | Marquet, A. | Bouvry, D. | +8

1
[1]